Vanguard Group Inc Cabaletta Bio, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,553,710 shares of CABA stock, worth $6.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,553,710

Previous 2,366,057 7.93%

Holding current value

$6.69 Million

Previous $17.7 Million 31.9%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.94 - $8.24 $739,352 - $1.55 Million	187,653 Added 7.93%	2,553,710 $12.1 Million
Q2 2024 Aug 13, 2024	BUY	$7.22 - $18.82 $648,608 - $1.69 Million	89,835 Added 3.95%	2,366,057 $17.7 Million
Q1 2024 May 10, 2024	BUY	$16.79 - $25.38 $2.42 Million - $3.66 Million	144,291 Added 6.77%	2,276,222 $38.8 Million
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $2 Million - $3.83 Million	163,823 Added 8.32%	2,131,931 $48.4 Million
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $2.92 Million - $4.6 Million	246,596 Added 14.32%	1,968,108 $30 Million
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $4.65 Million - $8.48 Million	607,569 Added 54.54%	1,721,512 $22.2 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $12.62 $1.31 Million - $2.33 Million	184,754 Added 19.88%	1,113,943 $9.21 Million
Q4 2022 Feb 10, 2023	SELL	$0.64 - $9.3 $223,591 - $3.25 Million	-349,362 Reduced 27.32%	929,189 $8.59 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $142,829 - $464,761	226,713 Added 21.55%	1,278,551 $831,000
Q1 2022 May 13, 2022	BUY	$1.68 - $3.92 $247,541 - $577,596	147,346 Added 16.29%	1,051,838 $2.14 Million
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $583,668 - $2.54 Million	173,711 Added 23.77%	904,492 $3.43 Million
Q3 2021 Nov 12, 2021	BUY	$7.0 - $12.5 $4,074 - $7,275	582 Added 0.08%	730,781 $8.89 Million
Q2 2021 Aug 13, 2021	BUY	$7.2 - $11.73 $5.26 Million - $8.57 Million	730,199 New	730,199 $6.28 Million

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cabaletta Bio, Inc. Transaction History